MAM
THRN

Martingale Asset Management’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Martingale Asset Management’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,024
Closed -$76K – 902
2022
Q3 		$76K Sell
16,024
-5,200
-25% -$26.1K ﹤0.01% 811
2022
Q2 		$103K Hold
21,224
– – ﹤0.01% 828
2022
Q1 		$135K Buy
+21,224
New +$114K ﹤0.01% 790

Other funds holding THRN

EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Martingale Asset Management's THRN Position: Q4 2022 in Review

Martingale Asset Management sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2022, closing a stake of 16,024 shares — an estimated $76K sold.

Martingale Asset Management first reported a position in THRN in Q1 2022 and held it in 3 quarters. The position peaked at $135K in Q1 2022. 45 funds tracked by Wall St. Rank hold THRN as of Q4 2022.

  • Martingale Asset Management reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Martingale Asset Management sold 16,024 Thorne Healthtech, Inc. Common Stock shares in Q4 2022, an estimated $76K.
  • Martingale Asset Management first reported a position in Thorne Healthtech, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Martingale Asset Management's Thorne Healthtech, Inc. Common Stock position peaked at $135K in Q1 2022.
  • 45 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2022.

Based on Martingale Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.